We are live on ! Find out more
ACM

Argyle Capital Management Portfolio holdings

AUM $347M
1-Year Est. Return 44.33%
This Fund
S&P 500
This Quarter Est. Return
+0.84%
1 Year Est. Return
+44.33%
3 Year Est. Return
+95.77%
5 Year Est. Return
+124.66%
10 Year Est. Return
+325.03%
AUM
$174M
AUM Growth
–
Cap. Flow
+$176M
Cap. Flow %
100.96%
Top 10 Hldgs %
24.86%
Holding
108
New
108
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$4.91M
2
BMY icon
Bristol-Myers Squibb
BMY
+$4.88M
3
MRK icon
Merck
MRK
+$4.75M
4
VZ icon
Verizon
VZ
+$4.67M
5
T icon
AT&T
T
+$4.31M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 23.77%
2 Technology 14.15%
3 Industrials 11.26%
4 Energy 10.86%
5 Consumer Staples 8.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SIGI icon
101
Selective Insurance
SIGI
$5.65B
$230K 0.13%
+10,002
New +$235K
CL icon
102
Colgate-Palmolive
CL
$73.1B
$225K 0.13%
+3,932
New +$233K
TXN icon
103
Texas Instruments
TXN
$252B
$209K 0.12%
+6,000
New +$214K
MUA icon
104
BlackRock MuniAssets Fund
MUA
$509M
$184K 0.11%
+14,600
New +$196K
OSUR icon
105
OraSure Technologies
OSUR
$279M
$137K 0.08%
+35,275
New +$157K
TLAB
106
DELISTED
TELLABS INC
TLAB
$29K 0.02%
+14,800
New +$30.4K
EK
107
DELISTED
EASTMAN KODAK CO
EK
$2K ﹤0.01%
+13,900
New +$2K
GNBT
108
DELISTED
GENEREX BIOTECHNOLOGY CORP
GNBT
$0 ﹤0.01%
+10,000
New –
1 2 3 4
5

Similar funds

GCP
Gill Capital Partners Denver, Colorado $348M AUM 14.74% 1-Year Est. Return
AWA
Argos Wealth Advisors Sacramento, California $348M AUM
WC
Winmill & Co Rochester, New York $347M AUM 37.48% 1-Year Est. Return
LAM
LOM Asset Management Hamilton $348M AUM 29.69% 1-Year Est. Return
FFA
Fi3 Financial Advisors Indianapolis, Indiana $346M AUM 25.49% 1-Year Est. Return
VW
Vance Wealth Santa Clarita, California $346M AUM 19.74% 1-Year Est. Return
1CP
11 Capital Partners Darien, Connecticut $348M AUM 19.84% 1-Year Est. Return
NC
Nokomis Capital Dallas, Texas $349M AUM 75.66% 1-Year Est. Return

Argyle Capital Management's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Argyle Capital Management, which disclosed 108 positions worth $174M. Its ten largest holdings account for 25% of the portfolio.

Its largest position is Pfizer: 177,740 shares worth $4.72M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, followed by Technology and Industrials.

  • Argyle Capital Management's largest Q2 2013 buy was Pfizer: 177,740 shares worth $4.72M.
  • Argyle Capital Management's ten largest holdings make up 25% of its $174M portfolio in Q2 2013.
  • Argyle Capital Management disclosed 108 positions in Q2 2013, its first 13F filing on record.

Based on Argyle Capital Management's 13F filing for Q2 2013, filed 31 Jul 2013.